|
Volumn 23, Issue 3 SUPPL. 6, 1996, Pages 7-10
|
Ifosfamide in non-small cell lung cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
ETOPOSIDE;
IFOSFAMIDE;
MESNA;
MITOMYCIN;
NAVELBINE;
PACLITAXEL;
VINDESINE;
BLOOD TOXICITY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RESEARCH;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG RESEARCH;
HUMAN;
LUNG NON SMALL CELL CANCER;
NEUROTOXICITY;
PRIORITY JOURNAL;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS, PHASE II;
EXPECTORANTS;
HUMANS;
IFOSFAMIDE;
LIVER;
LUNG NEOPLASMS;
MESNA;
RANDOMIZED CONTROLLED TRIALS;
REMISSION INDUCTION;
SURVIVAL RATE;
|
EID: 0029899710
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (9)
|
References (0)
|